Catalogo Articoli (Spogli Riviste)

OPAC HELP

Titolo:
ARRHYTHMOGENIC RIGHT-VENTRICULAR CARDIOMY OPATHY - ETIOLOGY, DIAGNOSIS, AND TREATMENT
Autore:
WICHTER T; BORGGREFE M; BREITHARDT G;
Indirizzi:
UNIV MUNSTER,MED KLIN & POLIKLIN,ALBERT SCHWEITZER STR 33 D-48129 MUNSTER GERMANY
Titolo Testata:
Medizinische Klinik
fascicolo: 4, volume: 93, anno: 1998,
pagine: 268 - 277
SICI:
0723-5003(1998)93:4<268:ARCO-E>2.0.ZU;2-9
Fonte:
ISI
Lingua:
GER
Soggetto:
STRUCTURAL HEART-DISEASE; ST SEGMENT ELEVATION; BUNDLE-BRANCH BLOCK; SIGNAL-AVERAGED ECG; LONG-TERM FOLLOW; ENDOMYOCARDIAL BIOPSY; CATHETER ABLATION; SUDDEN-DEATH; TIME-DOMAIN; DYSPLASIA;
Keywords:
CARDIOMYOPATHY; VENTRICULAR TACHYCARDIA; SUDDEN DEATH; DYSPLASIA; RIGHT VENTRICLE;
Tipo documento:
Article
Natura:
Periodico
Settore Disciplinare:
Science Citation Index Expanded
Citazioni:
56
Recensione:
Indirizzi per estratti:
Citazione:
T. Wichter et al., "ARRHYTHMOGENIC RIGHT-VENTRICULAR CARDIOMY OPATHY - ETIOLOGY, DIAGNOSIS, AND TREATMENT", Medizinische Klinik, 93(4), 1998, pp. 268-277

Abstract

Arrhythmogenic right ventricular cardiomyopathy (ARVC) is characterized by regional atrophy of right ventricular myocardium and subsequent replacement by fatty and fibrous tissue. The disease manifests in young adulthood with a predominance of males. Hallmarks of ARVC are ventricular tachyarrhythmias of left bundle branch block pattern which frequently occur during exercise. However, sudden death may also be the first manifestation of the disease. Characteristic findings are repolarization abnormalities and QRS prolongation in the right precordial leadsof the surface ECG and regional abnormalities of right ventricular structure and wall motion. Left ventricular involvement may occur in later stages of the disease but rarely leads to progressive biventricularheart failure. Therapeutic efforts are mainly directed to the treatment of ventricular tachyarrhythmias and the prevention of sudden death. A tailored treatment strategy including antiarrhythmic drug therapy, catheter ablation and implantation of cardioverter-defibrillators may be used to improve the long-term prognosis of patients with ARVC.

ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 02/07/20 alle ore 23:37:49